Thus, colon cancer cells expressing truncated APC may tolerate a wild-type APCL because it displays a leaky activity, allowing β-catenin to escape degradation in a sufficient amount to initiate tumourigenesis. Here, APC2 is linked to malignant colon neoplasm.